Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colorectal Cancer Metastatic × Leucovorin × Clear all

Phase

Phase 2 6 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 110 Colonic Neoplasms 62 Rectal Neoplasms 53 Neoplasm Metastasis 21 Pancreatic Neoplasms 18 Stomach Neoplasms 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Neoplasms 10 Leukemia 9 Carcinoma, Hepatocellular 9 Lymphoma 8 Adenocarcinoma Of Esophagus 8 Burkitt Lymphoma 7 Cholangiocarcinoma 6 Esophageal Neoplasms 5 Adenocarcinoma 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Intestinal Neoplasms 4 Gastrointestinal Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Digestive System Neoplasms 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Gallbladder Neoplasms 3 Biliary Tract Neoplasms 3 Rectal Diseases 2 Neurotoxicity Syndromes 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Biphenotypic, Acute 2

Interventions

aflibercept 3 Irinotecan 2 Bevacizumab 2 XELOX 1 Vemurafenib 1 Panitumumab 1 Leucovorin 1 IFL protocol 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01670721 2016-11-28

AFEQT

Sanofi

Phase 3 Completed

175 enrolled 6 charts

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡